Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Assets (2016 - 2025)

INVO Fertility (IVF) has disclosed Assets for 15 consecutive years, with $18.8 million as the latest value for Q3 2025.

  • Quarterly Assets rose 70.57% to $18.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $18.8 million through Sep 2025, up 70.57% year-over-year, with the annual reading at $46.4 million for FY2024, 151.0% up from the prior year.
  • Assets for Q3 2025 was $18.8 million at INVO Fertility, down from $19.3 million in the prior quarter.
  • The five-year high for Assets was $46.4 million in Q4 2024, with the low at -$375355.0 in Q1 2023.
  • Average Assets over 5 years is $12.0 million, with a median of $9.5 million recorded in 2021.
  • The sharpest move saw Assets plummeted 104.65% in 2023, then skyrocketed 64343.27% in 2025.
  • Over 5 years, Assets stood at $10.0 million in 2021, then plummeted by 62.88% to $3.7 million in 2022, then surged by 398.84% to $18.5 million in 2023, then skyrocketed by 151.0% to $46.4 million in 2024, then tumbled by 59.46% to $18.8 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $18.8 million, $19.3 million, and $31.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.